Featured
Read our handpicked blogs, curated for you.
|
The Rising Risk in Modern Digital WorkplacesEmployees share files across Teams, SharePoint, email, and external…
|
The AI Governance Challenge in 2026Copilot and autonomous AI agents are rolling out rapidly across enterprises. They…
|
The Control Crisis in Digital WorkplacesShadow IT, permission sprawl, and configuration drift create growing risks.…
Recent releases
|
Winning HCP engagement beyond metro cities
Healthcare in India doesn’t stop at Mumbai, Delhi, or Bangalore. Beyond the metros lies the bulk of India’s medical ecosystem: doctors in Tier 2 and Tier 3 cities who prescribe at scale, influence…
|
Why pharma marketing still flies blind in India
Indian pharma marketing is at a crossroads. Budgets are rising, regulations are tightening, and digital adoption is accelerating. Yet when senior leaders are asked the simplest boardroom question: “…
|
The cost of slow content in pharma marketing and how to amplify it
Every pharma marketer knows the story. A campaign is planned around a new therapy, the slides are drafted, medical-legal-regulatory begins its review, weeks pass, edits keep coming back, and by the…
|
UCPMP 2024 changes pharma marketers must act on
For years, pharma marketing in India carried a reputation for being stuck between outdated field-force practices and patchy digital adoption. That space has shifted. UCPMP 2024 is not just an update…
